Streamline Testing in Your Practice

The Reverse Transcription Polymerase Chain Reaction (RT-PCR) test is the “Gold Standard” test for COVID-19 and is recommended by the FDA and CDC since it is the most accurate type of diagnostic test available when testing for the SARS-CoV-2 virus (COVID-19).

Promus Diagnostics’ SARS-CoV-2 Quantitative Neutralizing Antibody Test (qNAT) provides not only a positive or negative result to prior infection but gives an individualized numerical value that can show immune response over time.

Promus Diagnostics UTI-ABR PCR panel detects 31 clinically significant pathogens that cause urinary tract infections, and 22 antimicrobial resistance markers, helping health care providers quickly identify the underlying causes of disease.

Promus Diagnostics’ RPP panel is used to detect specific respiratory pathogens to help diagnose viral infections such as COVID-19, flu, common cold, RSV, and pneumonia.

Promus Diagnostics’ CFR real-time RT-PCR test designed for the qualitative detection of RNA from the SARS-CoV-2, Influenza A/B, and Human Respiratory Syncytial Virus A/B in respiratory specimens from individuals suspected of infections by their healthcare provider.

Promus Diagnostics’ Pharmacogenetic testing (PGx) discovers genetic variants that can affect how your body processes a certain medication and can tell your physician what the most effective medication and dosage is for your specific body based on your unique DNA.